SCHEMBL30675620

SCHEMBL30675620

COc1cc(F)ccc1C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
KDM4E B2RXH2 3/20 0.53
HPGD P15428 2/20 0.53
HTT P42858 2/20 0.53
HSD17B10 Q99714 1/20 0.51
PPARG P37231 1/20 0.50
PPARA Q07869 1/20 0.50
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
LMNA P02545 1/20 0.49
MAPK1 P28482 1/20 0.49
MAPT P10636 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
KEAP1 Q14145 1/20 0.48
LCK P06239 1/20 0.47
FYN P06241 1/20 0.47
ACLY P53396 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL927338 1.00 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDHTTHSD17B10
Hydrochloric Acid SCHEMBL10990786 0.98 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL21327584 0.87 HTT (0.71) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL27709578 0.86 NPC1 (0.51) ALDH1A1HTTRAB9ANPC1SMN1; SMN2
SCHEMBL3133634 0.86 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL9461812 0.85 CDC25B (0.60) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL22117367 0.85 RAB9A (0.47) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL113562 0.85 KEAP1 (0.53) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL29622845 0.85 KEAP1 (0.53) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL1020142 0.85 SMN1; SMN2 (0.49) ALDH1A1KDM4EHPGDHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630549-B2 Pyrazoleamide derivatives HOFFMANN-LA ROCHE INC. (US) 2026-05-19 US disclosed
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES P2RY1, P2RX1, P2RX5 ALDH1A1 203/4885KDM4E 2850/4885HPGD 611/4885
US-12630549-B2 Pyrazoleamide derivatives CYP11B2, CYP11B1, ADRA1B ALDH1A1 439/4885KDM4E 3127/4885HPGD 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.